Ivabradine as an Adjuvant Agent for Severe Heart Failure Occurring in the Early Phase after Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Ivabradine as an Adjuvant Agent for Severe Heart Failure Occurring in the Early Phase after Allogeneic Hematopoietic Cell Transplantation

Published:2022-09-15 Issue:18 Volume:61 Page:2779-2784
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yanagiya Ryo¹,Wanezaki Masahiro²,Nakamura Naohisa³,Ichikawa Tsubasa¹,Hayasaka Tatsuya³,Yamada Akane¹,Aizawa Keiko¹,Ito Satoshi¹,Himuro Masahito¹,Suzuki Hiroto³,Yamamoto Masakazu¹,Toubai Tomomi¹,Watanabe Masafumi²,Ishizawa Kenichi¹

Affiliation:

1. Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology (3rd Department of Internal Medicine), Faculty of Medicine, Yamagata University, Japan

2. 1st Department of Internal Medicine, Faculty of Medicine, Yamagata University, Japan

3. Department of Critical Care Unit, Yamagata University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/61/18/61_7946-21/_pdf

Reference16 articles.

1. 1. Passweg JR, Baldomero H, Bader P, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant 51: 786-792, 2016.

2. 2. The Japanese Data Center for Hematopoietic Stem Cell Transplantation. Performance of hematopoietic stem cell transplantation in Japan [Internet]. [cited 2021 Mar 8]. Available from: https://www.jdchct.or.jp/data/slide/2016/transplants_2016_JDCHCT_20170324.pdf (in Japanese).

3. 3. Baker JK, Shank-Coviello J, Zhou B, et al. Cardiotoxicity in hematopoietic stem cell transplant: keeping the beat. Clin Lymphoma Myeloma Leuk 20: 244-251.e4, 2020.

4. 4. Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37: 2768-2801, 2016.

5. 5. Ishida S, Doki N, Shingai N, et al. The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ann Hematol 95: 1145-1150, 2016.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogenic Hematopoietic Cell Transplantation;Internal Medicine;2023-03-01

2. Response to: Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogeneic Hematopoietic Cell Transplantation;Internal Medicine;2023-03-01

3. Multiple drugs;Reactions Weekly;2022-11-05